![E. Scott Toner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
E. Scott Toner
Plus aucun poste en cours
Historique de carrière de E. Scott Toner
Anciens postes connus de E. Scott Toner
Sociétés | Poste | Début | Fin |
---|---|---|---|
OPKO HEALTH, INC. | Sales & Marketing | 09/04/2014 | 01/01/2015 |
REATA PHARMACEUTICALS, INC. | Sales & Marketing | 01/03/2011 | 01/12/2012 |
AMAG PHARMACEUTICALS, INC. | Sales & Marketing | 01/03/2007 | 01/10/2010 |
PROTARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2015 | - |
Sales & Marketing | 01/01/2015 | - | |
American Association of Kidney Patients, Inc. | Directeur/Membre du Conseil | - | - |
Formation de E. Scott Toner
Ithaca College | Undergraduate Degree |
Drexel University | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Sales & Marketing | 4 |
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
OPKO HEALTH, INC. | Health Services |
Entreprise privées | 4 |
---|---|
American Association of Kidney Patients, Inc. | |
Proteon Therapeutics, Inc.
![]() Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Reata Pharmaceuticals, Inc.
![]() Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
AMAG Pharmaceuticals, Inc.
![]() AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- E. Scott Toner
- Expérience